ARDM Market Cap History
Below is a table of the ARDM market cap history going back to 5/23/2014:

Date ARDM Market Cap
5/23/2014114.72M
6/11/2014140.02M
8/5/2014123.55M
11/5/2014113.54M
3/6/2015107.95M
5/7/2015100.58M
8/10/2015109.16M
11/5/201599.64M
3/7/201648.12M
5/7/201668.89M
8/8/201670.23M
11/8/201667.13M
3/12/201728.11M
5/4/201716.19M
8/8/201722.52M
10/26/201765.14M
3/12/201818.05M
5/4/201820.84M
8/8/201820.83M
11/5/201816.74M

Also see: ARDM Shares Outstanding History
and ARDM YTD Return
ARDM Historical Market Cap:
-35.06% CAGR
ARDM Historical Market Cap: +-35.06% CAGR

Mouse over chart for data details
5/23/2014 ...11/5/2018
Aradigm is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. Co.'s primary development candidates are proprietary formulations of the potent antibiotic ciprofloxacin (Linhaliq (ARD-3150) and Lipoquin® (ARD-3100)) that are delivered by inhalation for the management of infections associated with severe respiratory diseases such as non-cystic fibrosis bronchiectasis and cystic fibrosis. The formulations differ in the proportion of rapidly available and slow release ciprofloxacin. Co. is also investigating the treatment of pulmonary non-tuberculous mycobacteria infections. We show 20 historical shares outstanding datapoints in our ARDM shares outstanding history coverage, used to compute ARDM market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARDM market cap history over the course of time is important for investors interested in comparing ARDM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARDM versus a peer is one thing; comparing ARDM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARDM can fluctuate over the course of history. With this page we aim to empower investors researching ARDM by allowing them to research the ARDM market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ARDM:
ARDM SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aradigm (ARDM) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ARDX Market Cap History
ARNA Market Cap History
ARQL Market Cap History
ARRY Market Cap History
ARWR Market Cap History
ASMB Market Cap History
ASNS Market Cap History
ATEC Market Cap History
ATHX Market Cap History
ATNX Market Cap History
More Healthcare companies »

 

ARDM Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.